---
figid: PMC7578249__fimmu-11-02013-g0004
figtitle: Impaired monocytes function in ACLF
organisms:
- Mus musculus
- Rattus norvegicus
- Marmota monax
- Homo sapiens
- Hepatitis B virus
- Adenoviridae
- Pan troglodytes
organisms_ner:
- Rattus norvegicus
- Pan troglodytes
- Homo sapiens
- Marmota monax
- Mus musculus
- Danio rerio
pmcid: PMC7578249
filename: fimmu-11-02013-g0004.jpg
figlink: pmc/articles/PMC7578249/figure/F4/
number: F4
caption: Impaired monocytes function in ACLF. Monocytes present antigens through human
  leukocyte antigen class II molecules such as HLA-DR. Ongoing injury in ACLF decreases
  monocyte HLA-DR expression, escalates MERTK expression, and subsequently impairs
  monocyte function to control the infection. MERTK inhibits the monocyte inflammatory
  response through avoiding TLR activation and inflammatory cytokine production. High
  PD1 expressing CD4/CD8 T cells and Tregs constrain monocyte inflammatory cytokine
  production. IL-33 re-establishes monocyte HLA-DR expression along with CCR2 and
  the co-stimulatory molecule CD80 and restores inflammatory cytokine production through
  the activation of the ERK1/2 pathway. MERTK blockades inhibit SOCS signaling and
  improve the production of inflammatory cytokines. HLA-DR, Human leukocyte antigen-
  antigen D related; MERTK, MER tyrosine kinase; TLR, Toll-like receptor; PD-1, Programmed
  death-1; CCR2, Chemokine receptor 2; ERK, Extracellular signal-regulated kinases;
  SCOS, Suppressor of cytokine signaling.
papertitle: 'Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets
  for Therapeutics.'
reftext: Arshi Khanam, et al. Front Immunol. 2020;11:2013.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9518995
figid_alias: PMC7578249__F4
figtype: Figure
redirect_from: /figures/PMC7578249__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7578249__fimmu-11-02013-g0004.html
  '@type': Dataset
  description: Impaired monocytes function in ACLF. Monocytes present antigens through
    human leukocyte antigen class II molecules such as HLA-DR. Ongoing injury in ACLF
    decreases monocyte HLA-DR expression, escalates MERTK expression, and subsequently
    impairs monocyte function to control the infection. MERTK inhibits the monocyte
    inflammatory response through avoiding TLR activation and inflammatory cytokine
    production. High PD1 expressing CD4/CD8 T cells and Tregs constrain monocyte inflammatory
    cytokine production. IL-33 re-establishes monocyte HLA-DR expression along with
    CCR2 and the co-stimulatory molecule CD80 and restores inflammatory cytokine production
    through the activation of the ERK1/2 pathway. MERTK blockades inhibit SOCS signaling
    and improve the production of inflammatory cytokines. HLA-DR, Human leukocyte
    antigen- antigen D related; MERTK, MER tyrosine kinase; TLR, Toll-like receptor;
    PD-1, Programmed death-1; CCR2, Chemokine receptor 2; ERK, Extracellular signal-regulated
    kinases; SCOS, Suppressor of cytokine signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mertk
  - Il33
  - Il1rap
  - Sult2a1
  - Il1rl1
  - Ephb1
  - Ccr2
  - Cd80
  - Tlr4
  - Il6
  - Il1b
  - Tnf
  - Cd4
  - MERTK
  - IL33
  - IL1RAP
  - CCR2
  - CD80
  - TLR4
  - IL6
  - IL1B
  - TNF
  - CD4
  - ST2
  - SULT2A1
  - IL1RL1
  - SDCBP2
  - EPHB2
  - MAPK1
  - MAPK3
  - HLA-DRA
  - HLA-DRB1
  - HLA-DRB3
  - HLA-DRB4
  - HLA-DRB5
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD8A
  - CD8B
  - CISH
  - XYLT2
  - SOS1
  - SOS2
  - Pdcd1
  - Cd8a
  - Ephb2
  - Mapk1
  - Cish
  - mertka
  - il1rap
  - ccr2
  - il6
  - il1b
  - tnfb
  - ighv1-1
  - cd4-1
---
